{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:22:49Z","timestamp":1789809769225,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA133322"],"award-info":[{"award-number":["R01CA133322"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-11-1-0533"],"award-info":[{"award-number":["W81XWH-11-1-0533"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Muirhead Chair Endowment at UTHSC (LP)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bbrc.2016.07.080","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T10:17:03Z","timestamp":1469096223000},"page":"128-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bortezomib sensitizes human glioblastoma cells to induction of apoptosis by type I interferons through NOXA expression and Mcl-1 cleavage"],"prefix":"10.1016","volume":"478","author":[{"given":"Ruishan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Davidoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence M.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.07.080_bib1","first-page":"151","article-title":"Brain tumor survival: results from the national cancer data base","volume":"40","author":"Surawicz","year":"1998","journal-title":"J.\u00a0Neuro-Oncol."},{"key":"10.1016\/j.bbrc.2016.07.080_bib2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1101\/gad.891601","article-title":"Malignant glioma: genetics and biology of a grave matter","volume":"15","author":"Maher","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2016.07.080_bib3","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.07.080_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1023668705040","article-title":"Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis","volume":"8","author":"Chawla-Sarkar","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2016.07.080_bib5","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1158\/0008-5472.CAN-11-2505","article-title":"Retinoic acid\/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets","volume":"72","author":"Dal Col","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.07.080_bib6","doi-asserted-by":"crossref","first-page":"31530","DOI":"10.1074\/jbc.M503120200","article-title":"IFN induces NIK\/TRAF dependent NF-\u03baB activation to promote cell survival","volume":"280","author":"Yang","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.080_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/jir.2011.0028","article-title":"The role of nuclear factor kappaB in the interferon response","volume":"31","author":"Pfeffer","year":"2011","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.bbrc.2016.07.080_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2016.07.080_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2005.10.001","article-title":"Life in the balance: how BH3-only proteins induce apoptosis","volume":"17","author":"Willis","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2016.07.080_bib10","doi-asserted-by":"crossref","first-page":"15561","DOI":"10.1074\/jbc.M412630200","article-title":"Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infection","volume":"280","author":"Sun","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.080_bib11","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1074\/jbc.M706021200","article-title":"Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation","volume":"283","author":"Bai","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.080_bib12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10428190801910912","article-title":"Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways","volume":"49","author":"Rizzatti","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2016.07.080_bib13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2010.06.005","article-title":"Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones","volume":"32","author":"Wensveen","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2016.07.080_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.immuni.2006.03.018","article-title":"The Noxa\/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells","volume":"24","author":"Alves","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2016.07.080_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1634\/theoncologist.8-6-508","article-title":"Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy","volume":"8","author":"Kane","year":"2003","journal-title":"Oncol."},{"key":"10.1016\/j.bbrc.2016.07.080_bib16","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/1078-0432.CCR-07-0871","article-title":"Bortezomib for the treatment of mantle cell lymphoma","volume":"13","author":"Kane","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.07.080_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.onc.1208225","article-title":"Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)","volume":"24","author":"Yin","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2016.07.080_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1158\/1535-7163.MCT-10-0725","article-title":"Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway","volume":"10","author":"Jane","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2016.07.080_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbrc.2016.07.080_bib20","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1158\/0008-5472.CAN-10-2579","article-title":"IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.07.080_bib21","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-10-2451","article-title":"Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway","volume":"17","author":"Naumann","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.07.080_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.surg.2011.07.044","article-title":"Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model","volume":"150","author":"Denbo","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.bbrc.2016.07.080_bib23","doi-asserted-by":"crossref","first-page":"13631","DOI":"10.1073\/pnas.250477397","article-title":"IFN\u03b1\/\u03b2 promotes cell survival by activating NF-\u03baB","volume":"97","author":"Yang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.07.080_bib24","doi-asserted-by":"crossref","first-page":"13756","DOI":"10.1074\/jbc.M011006200","article-title":"Interferon \u03b1\/\u03b2 promotes cell survival by activating NF-\u03baB through phosphatidylinositol-3 kinase and Akt","volume":"276","author":"Yang","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.07.080_bib25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ni.2397","article-title":"Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium","volume":"13","author":"Robinson","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbrc.2016.07.080_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4049\/jimmunol.169.2.847","article-title":"IFN-beta pretreatment sensitizes human melanoma cells to TRAIL\/Apo2 ligand-induced apoptosis","volume":"169","author":"Chawla-Sarkar","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.07.080_bib27","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1128\/JVI.79.14.9320-9324.2005","article-title":"Identification of TRAIL as an interferon regulatory factor 3 transcriptional target","volume":"79","author":"Kirshner","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2016.07.080_bib28","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1053\/j.gastro.2010.01.051","article-title":"Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection","volume":"138","author":"Stegmann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2016.07.080_bib29","first-page":"225","article-title":"Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1\/CIP1)","volume":"48","author":"Tanabe","year":"2000","journal-title":"J.\u00a0Neuro-Oncol."},{"key":"10.1016\/j.bbrc.2016.07.080_bib30","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1158\/1535-7163.MCT-05-0474","article-title":"Combination therapy with IFN-alpha plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells","volume":"5","author":"Papageorgiou","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2016.07.080_bib31","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1101\/gad.1304105","article-title":"Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins","volume":"19","author":"Willis","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2016.07.080_bib32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1073\/pnas.0308050100","article-title":"Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.07.080_bib33","doi-asserted-by":"crossref","first-page":"e71130","DOI":"10.1371\/journal.pone.0071130","article-title":"The curcumin analog EF24 targets NF-kappaB and miRNA-21, and has potent anticancer activity in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16312025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16312025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:12:45Z","timestamp":1757761965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16312025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0006291X16312025"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.080","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bortezomib sensitizes human glioblastoma cells to induction of apoptosis by type I interferons through NOXA expression and Mcl-1 cleavage","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}